Publications

5532 Results

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women.

Authors
J Crowley;S Green;CK Osborne
Journal / Conference
The Lancet 339(8784):1-5/71-85
Year
1992
Research Committee(s)
Breast

Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10 year results and review of the literature.

Authors
K Antman;L Ryan;E Borden;WC Wood;HL Lerner;JM Corson;R Carey;H Sult;S Balcerzak;A Elias;L Baker
Journal / Conference
Adjuvant Therapy of Cancer, SE Salmon (ed.)W.B. Saunders Co VI:529-542
Year
1991
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8291, SWOG-8391

A Southwest Oncology Group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer.

Authors
DD Von Hoff;R Kronmal;SE Salmon;J Turner;JB Green;JS Bonorris;EL Moorhead;HE Hynes;RP Pugh;RJ Belt;DS Alberts
Journal / Conference
Cancer 67(1):20-27
Year
1991
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8092

A randomized trial of cis-platinum, vinblastine, and bleomycin vs. vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: A Southwest Oncology Group study.

Authors
AJ Wozniak;MK Samson;NT Shah;ED Crawford;CD Ford;SJ Altman;RL Stephens;RB Natale;BA Bouroncle;B Blumenstein;GD Cummings
Journal / Conference
JCO 9(1):70-76
Year
1991
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8110

Phase II study of L-Alanosine (NSC-153353) in patients with advanced breast cancer. A Southwest Oncology Group study.

Authors
DD Von Hoff;S Green;JA Neidhart;C Fabian;T Budd;J Boyd;CK Osborne
Journal / Conference
IND 9:87-88
Year
1991
Research Committee(s)
Breast
Study Number(s)
SWOG-8304

Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer: A Southwest Oncology Group study.

Authors
DD Von Hoff;S Green;DS Alberts;DL Stock-Novack;EA Surwit;TP Miller;RL Stephens
Journal / Conference
AJCO 14(3):193-194
Year
1991
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8320

Evaluation of fludarabine phosphate in malignant melanoma. A Southwest Oncology Group study.

Authors
J Kish;K Kopecky;M Samson;DD Von Hoff;W Fletcher;R Kempf;F Muggia
Journal / Conference
IND 9:105-108
Year
1991
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8324

Phase II evaluation of fludarabine phosphate in patients with central nervous system tumors: A Southwest Oncology Group study.

Authors
SA Taylor;J Crowley;FS Vogel;JJ Townsend;HJ Eyre;KA Jaeckle;HE Hynes;JT Guy
Journal / Conference
IND 9:195-197
Year
1991
Research Committee(s)
Brain
Study Number(s)
SWOG-8400/05

Esorubicin in advanced endometrial cancer. An ineffective and potentially toxic therapy. A Southwest Oncology Group study.

Authors
JB Green;S Green;R O'Toole;DS Alberts;WA Nahhas;DL Wallace
Journal / Conference
IND 9:191-193
Year
1991
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8408

Second-line treatment of advanced measurable ovarian cancer with iproplatin: A Southwest Oncology Group study.

Authors
G Weiss;S Green;DS Alberts;JT Thigpen;HE Hynes;K Hanson;HI Pierce;LH Baker;JW Goodwin
Journal / Conference
EJCO 27(2):135-138
Year
1991
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8500